Christopher M Palmer is a Belmont, Massachusetts based psychiatrist who is specialized in Psychiatry. His current practice location is 115 Mill Street, Mclean Hospital, Belmont. Patients can reach him at 617-855-2180. Christopher M Palmer is M.D. in Psychiatry and his NPI number (Unique professional ID assigned by NPPES) is 1134167414. Christopher M Palmer specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.
Complete Profile:
Christopher M Palmer speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1134167414
NPI Enumeration Date:
02 Jun, 2006
NPI Last Update On:
08 Jul, 2007
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Christopher M Palmer 115 Mill Street, Mclean Hospital Belmont, Massachusetts
Zip:
02478
Phone Number:
617-855-2180
Patients can reach Christopher M Palmer at 115 Mill Street, Mclean Hospital, Belmont, Massachusetts or can call to book an appointment on 617-855-2180.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.